1. Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression

   • Hildegund C. J. Ertl

   Leading Article 30 January 2023 Pages: 287 - 298

   

2. Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases

   • Paulina Núñez
   • Rodrigo Quera
   • Andres J. Yarur

   Review Article Open access 13 March 2023 Pages: 299 - 314

   

3. Evolving Trends in Consumption of Direct Oral Anticoagulants in 65 Countries/Regions from 2008 to 2019

   • Vincent K. C. Yan
   • Hang-Long Li
   • Esther W. Chan

   Original Research Article 25 February 2023 Pages: 315 - 340

   

4. Olutasidenib: First Approval

   • Connie Kang

   AdisInsight Report 27 February 2023 Pages: 341 - 346

   

5. Etranacogene Dezaparvovec: First Approval

   • Young-A Heo

   AdisInsight Report 21 February 2023 Pages: 347 - 352

   

6. Nadofaragene Firadenovec: First Approval

   • Arnold Lee

   AdisInsight Report Open access 01 March 2023 Pages: 353 - 357

   

7. Lecanemab: First Approval

   • Sheridan M. Hoy

   AdisInsight Report 01 March 2023 Pages: 359 - 365